Pharmacy and Therapeutics (P&T) committees historically operated at the individual hospital level but have evolved into enterprise-wide governance programs due to health system expansion, unprecedented clinical and financial complexity of care, and the emergence of high impact and novel therapeutics.

To address this, the Vizient Center for Pharmacy Practice Excellence convened an expert panel that concluded health system enterprise P&T committees are uniquely positioned to balance clinical value with financial stewardship and minimize practice variation. They issued best practice considerations representing a dynamic framework designed to evolve alongside emerging therapies, evolving technologies, and the ongoing transformation of health systems.

Joining us today are two members of the expert panel. We have Conor Hanrahan, AVP, enterprise pharmacy services, medication outcomes and stewardship with Intermountain Health and Prabashni Reddy, who at the time of the panel was the executive director of medication use and policy at Mass General Brigham.

Guest speakers: 

Prabashni Reddy, RPh, PharmD, MMedSc

Mass General Brigham

Intermountain Health, Enterprise Pharmacy Services

Host:

Kerry Schwarz, PharmD, MPH  

Senior Clinical Manager, Evidence-Based Medicine and Outcomes 

Center for Pharmacy Practice Excellence (CPPE)

Show Notes: 

[01:02-03:38] The value Prabashni and Conor saw in joining the expert panel

[03:39-05:33] What Prabashni and Conor learned from interactions during the expert panel 

[05:34-10:55] Intriguing actionable enterprise P&T program insights panelists brought to the table that listeners can use

[10:56-14:01] Use of criteria and principles to create successful and broadly applicable best practices

[14:56-16:00] How our listeners can put this panel's best practices into action

VerifiedRx Listener Feedback Survey:

We would love to hear from you - Please click here

Subscribe Today!

Apple Podcasts

Spotify

YouTube

RSS Feed